Lynn Seely

Insider Reports History

Location
501 2 Nd Street, Suite 211, San Francisco, CA
Signature
/s/ Charles W. Newton, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lynn Seely:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. President and CEO, Director Common Stock 67.6K $712K $10.54 Aug 21, 2025 Direct
Blueprint Medicines Corp Director Common Stock 0 $0 $101.84 Jul 17, 2025 Direct
Lyell Immunopharma, Inc. President and CEO, Director Option (right to buy) 169K Feb 10, 2025 Direct
Blueprint Medicines Corp Director Stock Option (Right to Buy) 0 Jul 17, 2025 Direct

Insider Reports Filed by Lynn Seely

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LYEL Lyell Immunopharma, Inc. Aug 20, 2025 2 -$76.5K 4 Aug 22, 2025 President and CEO, Director
LYEL Lyell Immunopharma, Inc. Aug 11, 2025 2 -$8.31K 4 Aug 13, 2025 President and CEO, Director
BPMC Blueprint Medicines Corp Jul 17, 2025 12 $0 4 Jul 21, 2025 Director
BPMC Blueprint Medicines Corp Jun 18, 2025 1 $500K 4 Jun 24, 2025 Director
LYEL Lyell Immunopharma, Inc. Mar 14, 2025 1 $106K 4 Mar 18, 2025 President and CEO, Director
LYEL Lyell Immunopharma, Inc. Feb 10, 2025 3 $0 4 Feb 26, 2025 President and CEO, Director
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
LYEL Lyell Immunopharma, Inc. Feb 9, 2024 1 $0 4 Feb 13, 2024 President and CEO, Director
LYEL Lyell Immunopharma, Inc. Nov 16, 2023 2 $0 4 Nov 20, 2023 President and CEO, Director
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
LYEL Lyell Immunopharma, Inc. Dec 15, 2022 1 $0 4 Dec 19, 2022 President and CEO, Director
BPMC Blueprint Medicines Corp Jun 21, 2022 2 $0 4 Jun 30, 2022 Director
LYEL Lyell Immunopharma, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Director
BPMC Blueprint Medicines Corp Jun 2, 2021 2 $0 4 Jun 4, 2021 Director